Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...
Researchers at the Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage ...
If you're new to cocktails or want to broaden your horizons to a drink that feels more upscale, it helps to know the best way ...
Data integrity is key to the success of any cell therapy program. CDMOs can implement robust data management systems for ...
DOVER, DE, UNITED STATES, January 21, 2026 /EINPresswire.com/ -- The global pharmaceutical supply chain is currently ...
Strategy's $76,000 average cost creates structural test for Bitcoin as on-chain metrics show stalled growth and weak holder ...
A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.
Engineers could avoid expensive redesigns by planning medical device testing early in development with expert guidance.
Study Finds on MSN
Blood Test Accurately Detects 81% Of Earliest Lung Cancers By Looking For Molecular Chaos
In A Nutshell Johns Hopkins researchers developed a blood test that catches 81% of stage IA lung cancers (the earliest, most ...
As COVID-19 testing becomes less routine, official case numbers can make outbreaks look smaller than they really are. A ...
The Trump administration is eliminating four out of six planned locations for a 2030 census practice test. The test, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results